Phase III results revealed today at The International Liver Congress 2015 show that once-daily treatment with daclatasvir (DCV) plus sofosbuvir (SOF) resulted in an overall 97% sustained virologic response (SVR) at 12 weeks ...
Apr 23, 2015
0
11
(HealthDay)—Sofosbuvir-velpatasvir is effective for hepatitis C virus (HCV), regardless of genotype, according to three studies published online Nov. 17 in the New England Journal of Medicine. The research was published ...
Nov 18, 2015
0
11
Having certain genetic variants could explain why people can develop type 1 diabetes at markedly different ages, including later in life, says new University of Exeter research being presented at this year's annual meeting ...
Sep 12, 2017
0
3
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?
Oct 12, 2018
0
56
Both environmental and genetic risk factors contribute to development of lung cancer. Tobacco smoking is the most well-known environmental risk factor associated with lung cancer. A Dartmouth research team led by Yafang Li, ...
Oct 26, 2017
0
20
Results presented today at The International Liver Congress 2015 show that a 12-week oral regimen of once-daily single tablet grazoprevir/elbasvir (GZR/EBR) is effective and well-tolerated in treatment-naive (TN) patients ...
Apr 24, 2015
0
4
The drug combination sofosbuvir/velpatasvir (trade name: Epclusa) has been approved since July 2016 for the treatment of patients with chronic hepatitis C (CHC). In an early benefit assessment, the German Institute for Quality ...
Oct 17, 2016
0
1
(Medical Xpress)—A new study has revealed how the spread of hepatitis B coincides with dates of human migration throughout history, starting around 40 000 years ago. The study could provide a framework for studying the ...
Oct 11, 2012
0
0
A new research paper titled "Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention" has been published in Oncotarget.
Nov 22, 2022
0
10
A gene so powerful it nearly triples the risk of Alzheimer's disease has been discovered by an international team including researchers from Mayo Clinic. It is the most potent genetic risk factor for Alzheimer's identified ...
Nov 14, 2012
0
0
